These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7380035)

  • 21. [Effect of butamide, cyclamide, chlorcyclamide and chloropropamide on the glycogen content in various tissues].
    GENES SG; MAKAREVICH-GAL'PERIN LM; USHENKO SN
    Vopr Med Khim; 1960; 6():469-74. PubMed ID: 13704349
    [No Abstract]   [Full Text] [Related]  

  • 22. [Biopharmaceutical aspects of butamide tablets].
    Voronina LM; Zykova NIa; Salo DP; Tomas R
    Farm Zh; 1978; (1):87-8. PubMed ID: 631310
    [No Abstract]   [Full Text] [Related]  

  • 23. [Attempt at determining the fragmentary constant (f) of the sulfonylurea groups].
    Cloux JL; Crommen J; Delarge J; Pirard ML; Thunus L
    J Pharm Belg; 1988; 43(3):141-51. PubMed ID: 3171867
    [No Abstract]   [Full Text] [Related]  

  • 24. NMR search for polymorphic phase transformations in chlorpropamide form-A at high pressures.
    Wasicki J; Kozlenko DP; Pankov SE; Bilski P; Pajzderska A; Hancock BC; Medek A; Nawrocik W; Savenko BN
    J Pharm Sci; 2009 Apr; 98(4):1426-37. PubMed ID: 18623194
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimation of phenytoin in body fluids in the presence of sulphonyl urea compounds.
    Thürkow I; Wesseling H; Meijer DK
    Clin Chim Acta; 1972 Mar; 37():509-13. PubMed ID: 5022115
    [No Abstract]   [Full Text] [Related]  

  • 26. PMR spectrometric analysis of chlorpropamide.
    Al-Badr AA
    Pharmazie; 1983 Aug; 38(8):568. PubMed ID: 6634931
    [No Abstract]   [Full Text] [Related]  

  • 27. [Example for a new alternative application of NIR spectroscopy in the parallel determination of active ingredients and an excipient in powders and tablets].
    Dávid AZ; Lengyel M; Marton S; Klebovich I; Antal I
    Acta Pharm Hung; 2005; 75(3):141-5. PubMed ID: 16318238
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circular dichroism studies on the interaction of sulfonylureas with bovine and human serum albumin.
    Müller WE; Wollert U
    Res Commun Chem Pathol Pharmacol; 1976 Mar; 13(3):551-4. PubMed ID: 819976
    [No Abstract]   [Full Text] [Related]  

  • 29. [The use of a method of solid-phase extraction for sample preparation in the identification of unknown substances by IR spectroscopy].
    Beliaev AV; Sorokin VI; Orlova OS; Kimstach TB
    Sud Med Ekspert; 1997; 40(3):23-8. PubMed ID: 9304249
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical evaluation of a new sulfonylurea (Ro-6-4563) in the treatment of stable diabetes in adults].
    Artega A; Soto S; Eyzaguirre J; Foradori A; Alliende ME
    Rev Med Chil; 1972 Jun; 100(6):635-8. PubMed ID: 5083349
    [No Abstract]   [Full Text] [Related]  

  • 31. [A contribution to the identification of the oral antidiabetic agent tolbutamide. 1st communication].
    Oelschläger H; Blume H
    Arzneimittelforschung; 1976; 26(3):303-12. PubMed ID: 989317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of a new sulfonylurea derivative, preparation SPC-703, based on a 5-year observation].
    Horoszek-Maziarz S; Berliński E; Jaromczyk-Slisz J; Rachoń K; Wójcikowski C; Słomiński M; Orłowska-Kunikowska E; Krupa-Wojciechowska B
    Pol Tyg Lek; 1985 May; 40(18):516-8. PubMed ID: 3892514
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hypoglycemic sulfamides and biguanides].
    Curchod B
    Z Krankenpfl; 1972 May; 65(5):190-3. PubMed ID: 4482790
    [No Abstract]   [Full Text] [Related]  

  • 34. [88 severe incidents of hypoglycemia in patients under treatment with sulfonylurea compounds. Results of a survey throughout Switzerland during 1968 and 1969].
    Berger W
    Schweiz Med Wochenschr; 1971 Jul; 101(28):1013-22. PubMed ID: 5141777
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of IR spectroscopy for the quantitative determination of drug preparations containing the carbonyl group].
    Mynka AF; Liuta ML
    Farm Zh; 1976; (4):34-8. PubMed ID: 1001418
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies on the formation of side products in the synthesis of tolbutamide using thin-layer chromatography].
    Menzer M; Prezewowski J; Haug U
    Pharmazie; 1971 Dec; 26(12):738-9. PubMed ID: 5141255
    [No Abstract]   [Full Text] [Related]  

  • 37. A dose equivalence study of glybenclamide (daonil)--a new hypoglycaemic agent.
    Mutalik GS; Mitra D; Oak VR; Nayak NJ
    J Assoc Physicians India; 1972 Mar; 20(3):229-34. PubMed ID: 4623893
    [No Abstract]   [Full Text] [Related]  

  • 38. [Glibornurid in treatment of diabetes mellitus].
    Rojszykowa E; Wrzesimski W
    Pol Tyg Lek; 1974 Jan; 29(2):63-6. PubMed ID: 4820789
    [No Abstract]   [Full Text] [Related]  

  • 39. Spectrophotometric determination of some catecholamine drugs using metaperiodate.
    el-Kommos ME; Mohamed FA; Khedr AS
    J Assoc Off Anal Chem; 1990; 73(4):516-20. PubMed ID: 2170322
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical evaluation of a new sulfonylurea in maturity onset diabetes - glipizide (K-4024).
    Bandisode MS; Boshell BR
    Horm Metab Res; 1976 Mar; 8(2):89-91. PubMed ID: 770300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.